line

News

Innovative Science Affordable Medicine

NEWS

Wellmarker Bio Grabs Attention at BIO KOREA 2019

Author
admin
Date
2019-05-22 16:27
Views
925

Wellmarker Bio Grabs Attention at BIO KOREA 2019
                  


Wellmarker Bio, a spin off company from Asan Medical Center attended ‘BIO KOREA 2019’ held from April 17-19th, 2019 in Seoul. At the convention, Wellmarker Bio attracted many investor’s attention, and was introduced by the media as one of the most promising bio-ventures in developing anticancer drugs.


Through internal and external collaborations, Wellmarker Bio is expanding its global networking and it is speeding up its development programs such as WM-S1(Colon cancer) and WM-A1(NSCLC).


For more information on pipelines, click here : http://www.wmbio.co/major-research/


Please refer to the following links for published articles: http://www.startup4.co.kr/news/articleView.html?idxno=15276 , http://www.bizhankook.com/bk/article/17604


Photo source: Biz.Hankook